Wellington Management Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-101,946
| Closed | -$8.27M | – | 2033 |
|
|
2025
Q1 | $8.27M | Buy |
101,946
+36,696
| +56% | +$2.98M | ﹤0.01% | 1248 |
|
|
2024
Q4 | $5.88M | Buy |
65,250
+12,689
| +24% | +$1.14M | ﹤0.01% | 1309 |
|
|
2024
Q3 | $5.19M | Buy |
52,561
+21,049
| +67% | +$2.08M | ﹤0.01% | 1322 |
|
|
2024
Q2 | $2.92M | Hold |
31,512
| – | – | ﹤0.01% | 1429 |
|
|
2024
Q1 | $2.99M | Hold |
31,512
| – | – | ﹤0.01% | 1441 |
|
|
2023
Q4 | $2.81M | Hold |
31,512
| – | – | ﹤0.01% | 1418 |
|
|
2023
Q3 | $2.3M | Sell |
31,512
-500
| -2% | -$36.5K | ﹤0.01% | 1448 |
|
|
2023
Q2 | $2.66M | Sell |
32,012
-2,100
| -6% | -$175K | ﹤0.01% | 1422 |
|
|
2023
Q1 | $2.6M | Sell |
34,112
-96,804
| -74% | -$7.38M | ﹤0.01% | 1449 |
|
|
2022
Q4 | $10.9M | Buy |
130,916
+102,204
| +356% | +$8.48M | ﹤0.01% | 1065 |
|
|
2022
Q3 | $2.28M | Sell |
28,712
-326,531
| -92% | -$25.9M | ﹤0.01% | 1495 |
|
|
2022
Q2 | $26.4M | Buy |
355,243
+286,644
| +418% | +$21.3M | 0.01% | 867 |
|
|
2022
Q1 | $6.17M | Buy |
68,599
+38,499
| +128% | +$3.46M | ﹤0.01% | 1338 |
|
|
2021
Q4 | $3.37M | Sell |
30,100
-240,400
| -89% | -$26.9M | ﹤0.01% | 1560 |
|
|
2021
Q3 | $34M | Sell |
270,500
-8,691
| -3% | -$1.09M | 0.01% | 931 |
|
|
2021
Q2 | $37.8M | Sell |
279,191
-667,385
| -71% | -$90.4M | 0.01% | 913 |
|
|
2021
Q1 | $128M | Buy |
946,576
+930,976
| +5,968% | +$126M | 0.02% | 535 |
|
|
2020
Q4 | $2.2M | Buy |
15,600
+6,500
| +71% | +$915K | ﹤0.01% | 1475 |
|
|
2020
Q3 | $1.01M | Buy |
9,100
+3,700
| +69% | +$412K | ﹤0.01% | 1549 |
|
|
2020
Q2 | $605K | Buy |
+5,400
| New | +$605K | ﹤0.01% | 1606 |
|
|
2017
Q1 | – | Sell |
-10,000
| Closed | -$592K | – | 2299 |
|
|
2016
Q4 | $592K | Buy |
+10,000
| New | +$592K | ﹤0.01% | 1965 |
|